Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PRPH Chart looks great today Conix!!!
PRPH I need $2.00 TODAY!!!!!!!!!!Come on now!!!!!
I like it Conix. Looks great. Thanks
1000 share bid whack at the open. What an idiot!!!!
All smoked out!! Would like to see a PRPH $2.00 bid by the end of the week...
Have a cigarette and relax.
Conix what a day, I'm spent... Thanks PRPH )
I'll let you know EOD. LOL 4 hrs from now. We're hitting PRPH HARD and LOOOONNNGGGGG!!!!
Hope it works for up to four hours. More than that, and we should call the doctor.
ROTFLMAO Conix. PRPH really swelling now!!!!!
Erecting a pretty good chart here on PRPH, midtown.
Conix we be creeping up to $2.00 soon. Looks like PRPH taking some of their own ED meds!!!LOL
PRPH steady low of $1.80. Looking good!!!!
PRPH price looks to have stabilized at a new high. Looking for next breakout...
Connie i'm not the 1 in 3 that need it, but if she's that HOTTT i'll take an extra 5 doses!!!!!!Go PRPH
Getting a hot girlfriend is a non-narcotic cure to ED.
PRPH spreading,
From Men's Health Digest:
Erectile dysfunction is a real and immediate concern for a sizable portion of the male population worldwide. One in three males suffer from ED!!1
Now that's a lot of $$$$$$$
PRPH enters into the $$$$multibillion male enhancement marketplace!!!!!
YW. GLTY. GO PRPH
Thanks for the heads up.
PRPH you might want to take a look at it now conix!!!!
PRPH new 52 week high!!! This baby is rocking!!!!
PRPH smoking hotttt today !!!!!!!!
I am now, great conf. call this morning from PRPH CEO. I see this moving back to it's 52 week high. JMHO
I just found it on my scanner this morning. I am putting a buy in at the bottom of the trend line @$1.50 the chart looks nice for a swing trade
Is anyone else following this stock??
Here is an interesting read by the CEO:
http://www.youngupstarts.com/2015/07/23/how-startups-can-beat-seasonality/
Karkus buys 200k shares and something brewing with this Phosphagenics???
http://www.topix.com/com/qgly/2015/06/1506058SF0CT
http://phosphagenics.com/wp-content/uploads/2015/07/2015-July-09-Phosphagenics-Newsletter.pdf
The Cold Eeze product always seems to get me through cold months. If a cold feels like it's going to set in, they are great to have handy.
Got a cold, zink it out.
Of course, friends think it's crazy to spend four, five to six dollars for 18 pieces.
That's why i always look for the boxes with 6 extra in it. Then i have to explain it is not simply a cough tablet, it's much more.
; )
Hello !.....is anybody home?
I was about to ask the same question. I'm looking into it but can't find anything yet.
$1.50 ProPhase: Matrixx Initiatives withdraws acquisition offer of $1.60/share for ProPhase Labs (PRPH) 1.70 :
LOL--I do not own any yet. Just threw it up on the board so others could see. For the record though--- Check the price now--and let's see the price in 3 months.
For giggles.
ok try buying 5 or 10k shares then selling them?
i'm not touching Matthew's latest favorite pick
good luck
I know. Low volume right now. Which is why the stock is down. Like a Catch 22.....
"I will buy it when there is more volume"
But if/when that volume comes in, the stock is already up 40% or so.
Never a free lunch. LOL
I know. Low volume right now. Which is why the stock is down. Like a Catch 22.....
"I will buy it when there is more volume"
But if/when that volume comes in, the stock is already up 40% or so.
Never a free lunch. LOL
excellent writeup however there doesnt seem to be too much interest in this stock
only 300 shares traded this morning
why bother?
NASDAQ:PRPH) sits around $1.00
Developer of Cold-EEZE® - clinically proven to shorten duration of common colds
ProPhase Labs researches, develops, manufactures, distributes, and markets over-the-counter (OTC) cold remedy and consumer products, natural base health products, and other supplements and cosmeceuticals in the United States.
Its OTC offerings include Cold-EEZE®, a zinc gluconate glycine product to reduce the duration and severity of the common cold symptoms; Kids-EEZE® soft chews to treat chest congestion, cough/cold, or allergies; and Organix® Complete cough/cold drops for coughs & sore throats due to colds.
The Company sells its consumer health products through national wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores, and pharmacies.
ProPhase Labs has a joint venture with Phusion Laboratories, LLC for the development and commercialization of non-prescription remedies using patented TPM technology. It also manufactures private label lozenges for retail customers; and manufactures, markets, and distributes a range of homeopathic and health products.
The CHEAP Investor Subscription-Based Newsletter has highlighted ProPhase Labs several times, and the stock has been a profitable investment for our subscribers in the past. Our last profile was in the December issue at $0.87, and it soared 83% to a high of $1.59. Since the price has fallen back near the $1 level, we thought it was time to take another look at ProPhase:
In November 2005, the stock (called Quigley back then) was a Wall Street favorite, selling at $16.80, when its major product, ColdEEZE, was a hot new product.
The Company has a good balance sheet with $4.6 million ($0.32 per share) in cash, a book value of $0.87 per share and no debt. Insiders own approximately 44% of the 14.6 million total shares outstanding, and institutions own 6% of the float (shares in public hands). This past quarter, insiders have purchased 300,000 shares at prices ranging between $0.85 and $0.95.
For the year ended December 31, 2011 revenues were up 20% to $17.5 million and net loss of $2.7 million was down from a loss of $3.6 million a year ago. There are only a total of 14.6 million shares outstanding.
Ted Karkus Chairman and CEO states, "Our success in building revenues in fiscal 2011 demonstrates that we now have a stronger distribution platform to launch new products and applications. In August 2011 we launched Cold-EEZE® Oral Spray which provides the same active ingredients for shortening the duration of the common cold as our clinically proven Cold-EEZE® lozenges, but in a new and convenient delivery system. This introduction was a natural next step in our evolution as a Company and at the core of our strategy to provide additional cold relief products for our loyal consumers that leverages our flagship Cold-EEZE® brand and adds incremental revenues for our Company. Initial retail and consumer response to our Cold-EEZE® Oral Spray is encouraging. We also hope to launch an additional Cold-EEZE® branded cold remedy product in the third quarter of fiscal 2012."
CONCLUSION
With a market cap of only $15 million and a very well-known product line, ProPhase could be an acquisition candidate. In our opinion, we believe the stock has long-term potential. To Continue researching ProPhase Labs, Inc., 621 North Shady Retreat Road, Doylestown, Pennsylvania 18901 or call 215-345-0919. The fax number is 215-345-5920. The Website:http://www.prophaselabs.com.
FULL DISCLOSURE
The CHEAP Investor has NOT BEEN COMPENSATED in anyway for this profile of (NASDAQ:PRPH) ProPhase Labs, Inc. and has chosen to profile this company based on the merits and fundamentals of the company. To the best of our knowledge, neither Mathews and Associates Inc., any of it's employees or any associate in connection with the distribution of this material own any shares and Hold No Position in (NASDAQ:PRPH) that could benefit as a result of this disseminated information.
Bill Mathews, the Editor of The CHEAP Investor, has been a long-term shareholder of (NASDAQ:PRPH) ProPhase Labs, Inc. and currently holds a position of 8,300 shares in his family portfolio which he has committed to hold and Will Not Sell for a Minimum Period of 90 Days following the release of this profile.
Try this again.. ~ Monday! $PRPH ~ Earnings posted, pending or coming soon! In Charts and Links Below!
~ $PRPH ~ Earnings expected on Monday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=PRPH&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=PRPH&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=PRPH
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=PRPH#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=PRPH+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=PRPH
Finviz: http://finviz.com/quote.ashx?t=PRPH
~ BusyStock: http://busystock.com/i.php?s=PRPH&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=PRPH >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
~ Tuesday! $PRPH ~ Earnings posted, pending or coming soon! In Charts and Links Below!
~ $PRPH ~ Earnings expected on Tuesday *
Want more like this? Search Keyword: MACMONEY >>> http://tinyurl.com/MACMONEY <<<
One or more of many earnings sites has alerted this security has or will be posting earnings on or around the day of this message.
http://stockcharts.com/h-sc/ui?s=PRPH&p=D&b=3&g=0&id=p88783918276&a=237480049
http://stockcharts.com/h-sc/ui?s=PRPH&p=W&b=3&g=0&id=p54550695994
~ Google Finance: http://www.google.com/finance?q=PRPH
~ Google Fin Options: hhttp://www.google.com/finance/option_chain?q=PRPH#
~ Yahoo! Finance ~ Stats: http://finance.yahoo.com/q/ks?s=PRPH+Key+Statistics
~ Yahoo! Finance ~ Profile: http://finance.yahoo.com/q/pr?s=PRPH
Finviz: http://finviz.com/quote.ashx?t=PRPH
~ BusyStock: http://busystock.com/i.php?s=PRPH&v=2
<<<<<< http://www.earningswhispers.com/stocks.asp?symbol=PRPH >>>>>>
http://investorshub.advfn.com/boards/post_prvt.aspx?user=251916
*If the earnings date is in error please ignore error. I do my best.
Followers
|
12
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
95
|
Created
|
06/20/11
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |